These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24642166)

  • 1. Kinetic and structural analysis of the irreversible inhibition of human monoamine oxidases by ASS234, a multi-target compound designed for use in Alzheimer's disease.
    Esteban G; Allan J; Samadi A; Mattevi A; Unzeta M; Marco-Contelles J; Binda C; Ramsay RR
    Biochim Biophys Acta; 2014 Jun; 1844(6):1104-10. PubMed ID: 24642166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.
    Bautista-Aguilera OM; Esteban G; Bolea I; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Samadi A; Soriano E; Unzeta M; Marco-Contelles J
    Eur J Med Chem; 2014 Mar; 75():82-95. PubMed ID: 24530494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
    Bolea I; Juárez-Jiménez J; de Los Ríos C; Chioua M; Pouplana R; Luque FJ; Unzeta M; Marco-Contelles J; Samadi A
    J Med Chem; 2011 Dec; 54(24):8251-70. PubMed ID: 22023459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids.
    Bautista-Aguilera OM; Esteban G; Chioua M; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Soriano E; Samadi A; Unzeta M; Marco-Contelles J
    Drug Des Devel Ther; 2014; 8():1893-910. PubMed ID: 25378907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine, a new cholinesterase and monoamine oxidase dual inhibitor.
    Bautista-Aguilera OM; Samadi A; Chioua M; Nikolic K; Filipic S; Agbaba D; Soriano E; de Andrés L; Rodríguez-Franco MI; Alcaro S; Ramsay RR; Ortuso F; Yañez M; Marco-Contelles J
    J Med Chem; 2014 Dec; 57(24):10455-63. PubMed ID: 25418133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of novel monoamine oxidases and cholinesterases targeting compounds on brain neurotransmitters and behavior in rat model of vascular dementia.
    Stasiak A; Mussur M; Unzeta M; Samadi A; Marco-Contelles JL; Fogel WA
    Curr Pharm Des; 2014; 20(2):161-71. PubMed ID: 23701539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donepezil-like multifunctional agents: Design, synthesis, molecular modeling and biological evaluation.
    Wu MY; Esteban G; Brogi S; Shionoya M; Wang L; Campiani G; Unzeta M; Inokuchi T; Butini S; Marco-Contelles J
    Eur J Med Chem; 2016 Oct; 121():864-879. PubMed ID: 26471320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease.
    Wang L; Esteban G; Ojima M; Bautista-Aguilera OM; Inokuchi T; Moraleda I; Iriepa I; Samadi A; Youdim MB; Romero A; Soriano E; Herrero R; Fernández Fernández AP; Ricardo-Martínez-Murillo ; Marco-Contelles J; Unzeta M
    Eur J Med Chem; 2014 Jun; 80():543-61. PubMed ID: 24813882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine.
    Samadi A; de los Ríos C; Bolea I; Chioua M; Iriepa I; Moraleda I; Bartolini M; Andrisano V; Gálvez E; Valderas C; Unzeta M; Marco-Contelles J
    Eur J Med Chem; 2012 Jun; 52():251-62. PubMed ID: 22503231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer's disease.
    Li F; Wang ZM; Wu JJ; Wang J; Xie SS; Lan JS; Xu W; Kong LY; Wang XB
    J Enzyme Inhib Med Chem; 2016; 31(sup3):41-53. PubMed ID: 27384289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of rasagiline-related inhibitors to human monoamine oxidases: a kinetic and crystallographic analysis.
    Binda C; Hubálek F; Li M; Herzig Y; Sterling J; Edmondson DE; Mattevi A
    J Med Chem; 2005 Dec; 48(26):8148-54. PubMed ID: 16366596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurogenic and neuroprotective donepezil-flavonoid hybrids with sigma-1 affinity and inhibition of key enzymes in Alzheimer's disease.
    Estrada Valencia M; Herrera-Arozamena C; de Andrés L; Pérez C; Morales-García JA; Pérez-Castillo A; Ramos E; Romero A; Viña D; Yáñez M; Laurini E; Pricl S; Rodríguez-Franco MI
    Eur J Med Chem; 2018 Aug; 156():534-553. PubMed ID: 30025348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease.
    Sterling J; Herzig Y; Goren T; Finkelstein N; Lerner D; Goldenberg W; Miskolczi I; Molnar S; Rantal F; Tamas T; Toth G; Zagyva A; Zekany A; Finberg J; Lavian G; Gross A; Friedman R; Razin M; Huang W; Krais B; Chorev M; Youdim MB; Weinstock M
    J Med Chem; 2002 Nov; 45(24):5260-79. PubMed ID: 12431053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of purified human recombinant monoamine oxidases A and B by rasagiline and its analogues.
    Hubálek F; Binda C; Li M; Herzig Y; Sterling J; Youdim MB; Mattevi A; Edmondson DE
    J Med Chem; 2004 Mar; 47(7):1760-6. PubMed ID: 15027867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highlights of ASS234: a novel and promising therapeutic agent for Alzheimer's disease therapy.
    Romero A; Marco-Contelles J; Ramos E
    Neural Regen Res; 2020 Jan; 15(1):30-35. PubMed ID: 31535639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrometric evidence for the flavin-1-phenylcyclopropylamine inactivator adduct with monoamine oxidase N.
    Mitchell DJ; Nikolic D; Rivera E; Sablin SO; Choi S; van Breemen RB; Singer TP; Silverman RB
    Biochemistry; 2001 May; 40(18):5447-56. PubMed ID: 11331009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydride Abstraction as the Rate-Limiting Step of the Irreversible Inhibition of Monoamine Oxidase B by Rasagiline and Selegiline: A Computational Empirical Valence Bond Study.
    Tandarić T; Prah A; Stare J; Mavri J; Vianello R
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32858935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, structure-activity relationships and molecular modeling studies of new indole inhibitors of monoamine oxidases A and B.
    La Regina G; Silvestri R; Gatti V; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E
    Bioorg Med Chem; 2008 Nov; 16(22):9729-40. PubMed ID: 18951803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the structural basis of the selective inhibition of monoamine oxidase A by dicarbonitrile aminoheterocycles: role of Asn181 and Ile335 validated by spectroscopic and computational studies.
    Juárez-Jiménez J; Mendes E; Galdeano C; Martins C; Silva DB; Marco-Contelles J; do Carmo Carreiras M; Luque FJ; Ramsay RR
    Biochim Biophys Acta; 2014 Feb; 1844(2):389-97. PubMed ID: 24247011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a novel fluorine-18 labeled deuterated fluororasagiline ([(18)F]fluororasagiline-D2) radioligand for PET studies of monoamino oxidase B (MAO-B).
    Nag S; Lehmann L; Kettschau G; Toth M; Heinrich T; Thiele A; Varrone A; Halldin C
    Bioorg Med Chem; 2013 Nov; 21(21):6634-41. PubMed ID: 24012376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.